Oral investigational medication Ecopipam can reduce stuttering symptoms in adults from the initiation of therapy till eight weeks, according to the results of open-label, uncontrolled clinical trial led by a psychiatrist at the University of California, Riverside.
Positive results included increased speech fluency, faster reading completion, and shortened duration of stuttering events.
"Ecopipam was well tolerated by the study participants," said Dr. Gerald Maguire, chair of psychiatry and ...
Oral investigational medication Ecopipam can reduce stuttering symptoms in adults from the initiation of therapy till eight weeks, according to the results of open-label, uncontrolled clinical trial led by a psychiatrist at the University of California, Riverside.
Positive results included increased speech fluency, faster reading completion, and shortened duration of stuttering events.
"Ecopipam was well tolerated by the study participants," said Dr. Gerald Maguire, chair of psychiatry and ...
